$293 Million is the total value of Krensavage Asset Management, LLC's 12 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 60.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UTHR | Sell | UNITED THERAPEUTICS CORP | $40,600,000 | -5.7% | 460,944 | -14.7% | 13.85% | -16.2% |
| REGN | New | REGENERON PHARMACEUTICALS | $39,208,000 | – | 104,420 | +100.0% | 13.38% | – |
| MCK | Sell | MCKESSON CORP | $35,179,000 | -12.2% | 254,330 | -13.3% | 12.00% | -22.0% |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $33,911,000 | +35.8% | 313,556 | +23.0% | 11.57% | +20.7% |
| BIIB | Sell | BIOGEN INC | $32,612,000 | -20.7% | 109,904 | -37.8% | 11.13% | -29.5% |
| ENTA | Sell | ENANTA PHARMACEUTICALS INC | $30,234,000 | +0.9% | 489,385 | -1.9% | 10.32% | -10.3% |
| TARO | New | TARO PHARMACEUTICAL INDUS | $29,880,000 | – | 339,819 | +100.0% | 10.20% | – |
| ALKS | New | ALKERMES PLC | $18,464,000 | – | 905,078 | +100.0% | 6.30% | – |
| RTIX | Sell | RTI SURGICAL HDS INC | $9,943,000 | -10.3% | 3,628,963 | -6.7% | 3.39% | -20.3% |
| IVC | Sell | INVACARE CORP | $7,941,000 | -13.6% | 880,402 | -28.1% | 2.71% | -23.2% |
| GILD | Sell | GILEAD SCIENCES INC | $7,919,000 | -77.4% | 121,861 | -77.9% | 2.70% | -79.9% |
| ANAB | New | ANAPTYSBIO INC | $7,157,000 | – | 440,409 | +100.0% | 2.44% | – |
| AVNS | Exit | Avanos Medical Inc | $0 | – | -59,429 | -100.0% | -0.86% | – |
| ELAN | Exit | Elanco Animal Health Inc | $0 | – | -892,620 | -100.0% | -9.11% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-18
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITED THERAPEUTICS CORP | 36 | Q3 2023 | 18.1% |
| Enanta Pharmceuticals Inc | 35 | Q3 2023 | 16.7% |
| INVACARE CORP | 28 | Q3 2021 | 5.8% |
| RTI SURGICAL INC | 23 | Q2 2020 | 7.9% |
| MCKESSON CORP | 20 | Q3 2022 | 16.3% |
| BIOGEN INC | 19 | Q3 2023 | 16.0% |
| MERCK & CO. INC. | 18 | Q1 2019 | 11.1% |
| DIGIRAD CORP | 18 | Q1 2019 | 1.0% |
| REGENERON PHARMACEUTICALS | 16 | Q3 2023 | 16.1% |
| ALKERMES PLC | 16 | Q3 2023 | 14.1% |
View Krensavage Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SURGALIGN HOLDINGS, INC. | February 19, 2021 | 5,380,449 | 6.6% |
| RTI SURGICAL, INC. | February 14, 2019 | 3,852,567 | 6.1% |
| Aviragen Therapeutics, Inc. | February 15, 2018 | 2,292,058 | 5.9% |
| ENANTA PHARMACEUTICALS INC | February 15, 2017 | 883,902 | 4.6% |
| Biota Pharmaceuticals, Inc. | February 17, 2016 | 2,267,655 | 5.9% |
View Krensavage Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SCHEDULE 13G | 2024-02-27 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-15 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-16 |
| 13F-HR | 2023-02-15 |
| 13F-HR | 2022-11-15 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-17 |
| 13F-HR | 2022-02-15 |
View Krensavage Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.